UNSPSC 51162043: Ipratropium bromide/fenoterol hydrobromide

Ipratropium bromide/fenoterol hydrobromide is a fixed combination of an anticholinergic agent and beta2-adrenergic agonist in patients with Asthma and Chronic Obstructive Pulmonary Disease.

UNSPSC 51162043 Ipratropium bromide/fenoterol hydrobromide is a Commodity code covering pharmaceutical inhalation products for respiratory and pulmonary use, but the code shows negligible alignment with recent state and local procurement activity. Of twelve opportunities tagged to this code in the source dataset, none involve ipratropium bromide or fenoterol hydrobromide; instead, they cover emergency medical services pharmaceuticals and supplies (naloxone, BLS/ALS medications), long-term care facility pharmacy services, forensic drug reference standards, emergency medicine mobile applications, group purchasing organization membership for hospital systems, pharmacy benefits program networks, and informational events. The single opportunity with direct pharmaceutical scope—Tucson Fire Department's June 2026 RFP for BLS/ALS pharmaceuticals and VendNovation vending systems—involves emergency life support medications and inventory management software rather than bronchodilator inhalers. No solicitation in the dataset seeks ipratropium bromide/fenoterol hydrobromide specifically, nor do state and local buyers appear to be procuring this product line under this code at present.

The misalignment between code nominal scope and actual procurement activity suggests either systematic miscoding of opportunities in the source system or minimal market demand among state and local agencies for ipratropium bromide/fenoterol hydrobromide products under this UNSPSC designation. Recent activity concentrates in neighboring pharmaceutical and medical supply categories—emergency medicine, long-term care facility pharmacy operations, and pharmacy benefits networks—issued by counties (Collier, Dane, San Mateo, Seminole), cities (Tucson, Palm Bay), regional health authorities (West Texas Centers), and specialized procurement bodies. Geographic spread spans Florida, Wisconsin, Arizona, Texas, and Washington State. Unless your firm is positioned to supply ipratropium bromide/fenoterol hydrobromide as a line item within broader emergency medicine, institutional pharmacy, or group purchasing contracts, this code does not represent actionable market opportunity at this time.